BP USP Moxicine 0.5% Collyre

BP USP Moxicine 0.5% Collyre

Therapeutic Class:
Get Quote

BP USP Moxicine 0.5% Collyre is an antibiotic, used in the treatment of bacterial infections of the eye. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.

BP USP Moxicine 0.5% Collyre is for external use only. Take it in the dose and duration as advised by your doctor. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid. Avoid skipping any doses and finish the full course of treatment even if you feel better.

It may cause eye discomfort, dry eyes and burning sensation in the eyes immediately following application. However, these side effects are temporary and usually subside on their own. Inform your doctor if they persist for a longer duration. It may cause short term blurring of vision when first used. Use caution before driving or using machines. Do not wear contact lenses while using it.

Salt Composition: Moxifloxacin Hydrochloride BP
Strength: (0.5% w/v)
Pack Size: 5.0 ml in 1 bottle
Uses: Treatment of Bacterial eye infections
Table Header
Salt Composition
Moxifloxacin Hydrochloride BP
(0.5% w/v)
Pack Size
5.0 ml in 1 bottle
Treatment of Bacterial eye infections
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of BP USP Moxicine 0.5% Collyre which is also known as Moxifloxacin Hydrochloride BP and Manufactured by Niche Formulations. It is available in strength of (0.5% w/v) is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed